• Activity INFORMATION

  Overview

  Micro-learning opportunities were created in response to evidence that learning is maximized when delivered in short and focused ‘bursts.’ In this session, we will review the adverse health consequences of getting insufficient quality and quantities of sleep as well reviewing a new medication that has recently become available on the market!

   

  Handouts

  • Homestudy PDF :   22253H01.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify the health consequences of insomnia and an update on a new pharmacologic agent available to improve sleep disturbances

  Pharmacy Technician

  Identify the health consequences of insomnia and an update on a new pharmacologic agent available to improve sleep disturbances

• Activity ACCREDITATION

  Activity Type

  Application

  CE Broker

  20-951108

  Universal Activity Number

  Pharmacist 0798-0000-22-253-H01-P
  Pharmacy Technician 0798-0000-22-253-H01-T
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Tammie Lee  Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy Services and Pharmacy Residency Training, New York State Office of Mental Health Buffalo Psychiatric Center

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).